Telmisartan Supplier-Buyer Network — Trade Flow Analysis

Name: Telmisartan Supplier-Buyer Trade Network Dataset — 413+ Indian Exporters, 21+ Importers, 132+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Telmisartan supplier network, Telmisartan buyers, pharmaceutical export India, Telmisartan trade data

TransData Nexus

Telmisartan

India Pharmaceutical Trade Intelligence

$11.0B413 Suppliers132 CountriesHS 30049079

ExportsIndia → GERMANY98.4%India → HUNGARY0.5%

ImportsGERMANY → India$1.9B MALTA → India$18.5M

#1 Supplier: CIPLA LIMITED #1 Buyer: B LOGISTIK

Who Supplies Telmisartan? Top Manufacturers & Buyers 2026 — CIPLA LIMITED Leads | TransData Nexus | TransData Nexus

1CIPLA LIMITED

CIPLA LIMITED is the first-largest Telmisartan exporter from India, with a market share of 98.4% and a total export value of $10.8B across 1.6K shipments. Their average shipment value of $6.7M is above the market average of $990.0K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. B LOGISTIK GMBH is the dominant customer, accounting for 99.9% of this supplier's tracked business. Top customers include:

• B LOGISTIK GMBH — $10.8B across 1.6K shipments (99.9% of this supplier's total exports)

• B LOGISTIK GMBH — $6.5M across 1 shipments (0.1% of this supplier's total exports)

• BREATHEFREE LANKA PVT LTD — $1.6M across 0 shipments (0.0% of this supplier's total exports)

• BOEHRINGER INGELHEIM — $179.2K across 0 shipments (0.0% of this supplier's total exports)

• IBL LIMITED - Health — $82.3K across 0 shipments (0.0% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $6.7M is 573% above the market average of $990.0K, consistent with large-order contracts or value-added formulations.

2MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the second-largest Telmisartan exporter from India, with a market share of 0.5% and a total export value of $58.2M across 240 shipments. Their average shipment value of $242.4K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN HUNGARY KFT, is the dominant customer, accounting for 76.5% of this supplier's tracked business. Top customers include:

• MYLAN HUNGARY KFT, — $44.5M across 184 shipments (76.5% of this supplier's total exports)

• MYLAN PHARMACEUTICALS INC, — $11.1M across 46 shipments (19.1% of this supplier's total exports)

• MYLAN PHARMACEUTICALS INC, — $1.4M across 6 shipments (2.4% of this supplier's total exports)

• MYLAN HUNGARY KFT, — $957.8K across 4 shipments (1.6% of this supplier's total exports)

• MYLAN HUNGARY KFT, — $185.4K across 1 shipments (0.3% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (240 shipments) at a per-shipment value of $242.4K, indicating a broad distribution network with many smaller, regular orders.

3INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the third-largest Telmisartan exporter from India, with a market share of 0.1% and a total export value of $14.4M across 461 shipments. Their average shipment value of $31.2K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. LABORATORIOS SAVAL S.A. is the dominant customer, accounting for 60.6% of this supplier's tracked business. Top customers include:

• LABORATORIOS SAVAL S.A. — $8.7M across 280 shipments (60.6% of this supplier's total exports)

• ACCORD FARMA S.A. DE C.V. — $3.1M across 101 shipments (21.9% of this supplier's total exports)

• ACCORD FARMA S.A. DE C.V. — $1.6M across 52 shipments (11.3% of this supplier's total exports)

• TO THE ORDER — $600.5K across 19 shipments (4.2% of this supplier's total exports)

• RITEMED PHILS., INC. — $286.5K across 9 shipments (2.0% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (461 shipments) at a per-shipment value of $31.2K, indicating a broad distribution network with many smaller, regular orders.

4ARISTO PHARMACEUTICALS PRIVATE LIMITED

ARISTO PHARMACEUTICALS PRIVATE LIMITED is the fourth-largest Telmisartan exporter from India, with a market share of 0.1% and a total export value of $10.9M across 334 shipments. Their average shipment value of $32.5K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.

ARISTO PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. NORVIK ENTERPRISES is the dominant customer, accounting for 90.7% of this supplier's tracked business. Top customers include:

• NORVIK ENTERPRISES — $9.8M across 303 shipments (90.7% of this supplier's total exports)

• NORVIK ENTERPRISES — $594.2K across 18 shipments (5.5% of this supplier's total exports)

• PHARMAVISION LTD — $229.9K across 7 shipments (2.1% of this supplier's total exports)

• ADK PHARMACEUTICAL C — $113.4K across 3 shipments (1.0% of this supplier's total exports)

• SOUTH AMERICAN EXPRE — $75.5K across 2 shipments (0.7% of this supplier's total exports)

Key Insight: ARISTO PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (334 shipments) at a per-shipment value of $32.5K, indicating a broad distribution network with many smaller, regular orders.

5ALEMBIC PHARMACEUTICALS LIMITED

ALEMBIC PHARMACEUTICALS LIMITED is the fifth-largest Telmisartan exporter from India, with a market share of 0.1% and a total export value of $6.8M across 251 shipments. Their average shipment value of $27.0K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.

ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• APOTEX PTY LTD. — $2.9M across 107 shipments (42.6% of this supplier's total exports)

• RANBAXY PHARMACEUTICALS — $1.6M across 61 shipments (24.2% of this supplier's total exports)

• PHARMA VISION PTY LT — $1.0M across 38 shipments (15.1% of this supplier's total exports)

• APOTEX PTY LIMITED — $703.5K across 26 shipments (10.4% of this supplier's total exports)

• ARROW PHARMACEUTICAL — $524.2K across 19 shipments (7.7% of this supplier's total exports)

Key Insight: ALEMBIC PHARMACEUTICALS LIMITED operates with high shipment frequency (251 shipments) at a per-shipment value of $27.0K, indicating a broad distribution network with many smaller, regular orders.

6GLENMARK PHARMACEUTICALS LIMITED

GLENMARK PHARMACEUTICALS LIMITED is the fifth-largest Telmisartan exporter from India, with a market share of 0.0% and a total export value of $3.4M across 532 shipments. Their average shipment value of $6.4K is below the market average of $990.0K, reflecting a high-volume, competitive pricing strategy.

GLENMARK PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• GLENMARK PHARMACEUTICALS INC., USA — $1.1M across 171 shipments (32.1% of this supplier's total exports)

• EGIS PHARMACEUTICALS PLC EGIS NYRT. — $1.1M across 169 shipments (31.7% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC., USA — $549.9K across 85 shipments (16.0% of this supplier's total exports)

• EG S.P.A — $357.8K across 55 shipments (10.4% of this supplier's total exports)

• GLENMARK PHARMACEUTICALS INC., USA — $334.0K across 52 shipments (9.7% of this supplier's total exports)

Key Insight: GLENMARK PHARMACEUTICALS LIMITED operates with high shipment frequency (532 shipments) at a per-shipment value of $6.4K, indicating a broad distribution network with many smaller, regular orders.

1Germany

Germany ranks as the first-largest destination for Telmisartan imports from India, with a total trade value of $10.8B across 1,540 shipments — representing a 98.4% share of all Telmisartan exports. The average shipment value of $7.0M is above the global average of $990.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Telmisartan importers in Germany: B LOGISTIK GMBH is the largest buyer, accounting for 100.0% ($10.8B) of this market's total imports.

• B LOGISTIK GMBH — $10.8B (100.0% of Germany's total)

Key Insight: Germany's per-shipment average of $7.0M (608% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Germany is a key market for Telmisartan imports from India.

Primary Market

Secondary Market

2Hungary

Hungary ranks as the second-largest destination for Telmisartan imports from India, with a total trade value of $50.5M across 112 shipments — representing a 0.5% share of all Telmisartan exports. The average shipment value of $451.0K is below the global average of $990.0K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Telmisartan importers in Hungary: MYLAN HUNGARY KFT, is the largest buyer, accounting for 90.2% ($45.5M) of this market's total imports.

• MYLAN HUNGARY KFT, — $45.5M (90.2% of Hungary's total)

• TEVA PHAMACEUTICALS WORKS — $2.8M (5.5% of Hungary's total)

Key Insight: Hungary receives frequent, smaller shipments of Telmisartan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Hungary is a key market for Telmisartan imports from India.

Primary Market

Secondary Market

3United States

United States ranks as the third-largest destination for Telmisartan imports from India, with a total trade value of $26.6M across 247 shipments — representing a 0.2% share of all Telmisartan exports. The average shipment value of $107.5K is below the global average of $990.0K, consistent with generic/API volume purchasing. This market is served by 3 tracked buyers.

Named Telmisartan importers in United States: MYLAN PHARMACEUTICALS INC, is the largest buyer, accounting for 46.7% ($12.4M) of this market's total imports.

• MYLAN PHARMACEUTICALS INC, — $12.4M (46.7% of United States's total)

• GLENMARK PHARMACEUTICALS INC., USA — $2.6M (10.0% of United States's total)

• ASCEND LABORATORIES LLC — $2.3M (8.7% of United States's total)

Key Insight: United States receives frequent, smaller shipments of Telmisartan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

United States is a key market for Telmisartan imports from India.

Primary Market

Secondary Market

4Uganda

Uganda ranks as the fourth-largest destination for Telmisartan imports from India, with a total trade value of $11.8M across 177 shipments — representing a 0.1% share of all Telmisartan exports. The average shipment value of $66.6K is below the global average of $990.0K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.

Named Telmisartan importers in Uganda: NORVIK ENTERPRISES LIMITED is the largest buyer, accounting for 91.9% ($10.8M) of this market's total imports.

• NORVIK ENTERPRISES LIMITED — $10.8M (91.9% of Uganda's total)

Key Insight: Uganda receives frequent, smaller shipments of Telmisartan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Uganda is a key market for Telmisartan imports from India.

Primary Market

Secondary Market

5Philippines

Philippines ranks as the fifth-largest destination for Telmisartan imports from India, with a total trade value of $10.1M across 19 shipments — representing a 0.1% share of all Telmisartan exports. The average shipment value of $530.8K is below the global average of $990.0K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.

Named Telmisartan importers in Philippines: EUROASIA PHARMACEUTICALS INC is the largest buyer, accounting for 50.6% ($5.1M) of this market's total imports.

• EUROASIA PHARMACEUTICALS INC — $5.1M (50.6% of Philippines's total)

Key Insight: Philippines receives frequent, smaller shipments of Telmisartan — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Philippines is a key market for Telmisartan imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Telmisartan.
2.Flow Mapping: 413 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 11,086 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 132 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

11,086 Verified Shipments

413 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Telmisartan

Telmisartan

Who Supplies Telmisartan? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Telmisartan — Export Intelligence Video

Market Intelligence

Official References & Regulatory Resources

Who Supplies Telmisartan? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Telmisartan Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1CIPLA LIMITED

2MYLAN LABORATORIES LIMITED

3INTAS PHARMACEUTICALS LIMITED

4ARISTO PHARMACEUTICALS PRIVATE LIMITED

5ALEMBIC PHARMACEUTICALS LIMITED

6GLENMARK PHARMACEUTICALS LIMITED

From Indian Factories to Global Pharmacies — How Telmisartan Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Telmisartan Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Germany

2Hungary

3United States

4Uganda

5Philippines

People Also Ask — Telmisartan Supplier & Trade Network

Telmisartan Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology